Adaptive zone model predictive control with a glucose and velocity dependent dynamic cost function for an artificial pancreas
US-12128212-B2 · Oct 29, 2024 · US
US2016354588A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016354588-A1 |
| Application number | US-201615237742-A |
| Country | US |
| Kind code | A1 |
| Filing date | Aug 16, 2016 |
| Priority date | Feb 7, 2013 |
| Publication date | Dec 8, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Systems for delivery of therapeutic agents and related methods are disclosed. A sensing system is configured to detect a chemical in the vicinity of a patient and transmit a signal to a controller upon detection. A controller is configured to release a therapeutic agent which is transported to the site of interest. The controller communicates with an electronic medical records database, an alarm and a nurse call system.
Opening claim text (preview).
1 .- 20 . (canceled) 21 . A therapy delivery patch comprising a filter sheet for placement adjacent a patient's skin, an adhesive layer extending outwardly from the filter sheet and configured to attach to the patient's skin, a cover forming a space above the filter sheet, a therapeutic agent repository situated within the space, a flow controller situated within the space and operable to control a flow of therapeutic agent from the therapeutic agent repository through the filter sheet onto the patient's skin. 22 . The therapy delivery patch of claim 21 , wherein the flow controller is situated between the therapeutic agent repository and the filter sheet. 23 . The therapy delivery patch of claim 22 , wherein the flow controller comprises a valve. 24 . The therapy delivery patch of claim 22 , wherein the flow controller comprises a microfluidic pump. 25 . The therapy delivery patch of claim 21 , further comprising a processor situated in the space, the processor being configured to operate the flow controller to control the flow of therapeutic agent. 26 . The therapy delivery patch of claim 25 , further comprising at least one sensor that detects a chemical secretion of the patient. 27 . The therapy delivery patch of claim 26 , wherein the processor operates the flow controller to control the flow of therapeutic agent based on a signal received from the at least one sensor. 28 . The therapy delivery patch of claim 26 , wherein the at least one sensor extends through the filter sheet. 29 . The therapy delivery patch of claim 26 , wherein the at least one sensor is situated between the flow controller and the patient's skin. 30 . The therapy delivery patch of claim 26 , wherein the at least one sensor comprises one or more of the following: a metal oxide type semi-conductor (MOS) sensor, a capacitive sensor, an inductive sensor or a surface acoustic wave sensor. 31 . The therapy delivery patch of claim 26 , wherein the at least one sensor comprises a protein based biosensor. 32 . The therapy delivery patch of claim 31 , wherein the protein based biosensor comprises one or more of the following: an odarant binding protein (OBP), a sensory appendage protein (SAP), an odorant receptor, a gustatory receptor, a serpentine receptor, or an odarant degrading enzyme (ODE). 33 . The therapy deliver patch of claim 31 , wherein the at least one sensor further comprises an electrochemical transducer to generate an electrical signal in response to detection of a chemical by the protein based biosensor. 34 . The therapy delivery patch of claim 26 , wherein the at least one sensor detects an indication of Ischemia by detecting any one or more of the following: CO 2 , Urea, Urate, Chloride, Lactic Acid, CO 2 /O 2 or O 2 . 35 . The therapy delivery patch of claim 26 , wherein the at least one sensor detects a 1L-1α and Creatine Phosphokinase (CPK) which is indicative of wound development. 36 . The therapy delivery patch of claim 21 , wherein the therapeutic agent comprises a vasodilator. 37 . The therapy delivery patch of claim 36 , wherein the vasodilator comprises one or more of the following: histamine, niacin, potassium or nitric acid. 38 . The therapy delivery patch of claim 21 , wherein the cover forms a dome over the filter sheet. 39 . The therapy delivery patch of claim 38 , wherein a bottom of the dome is located near a junction between the adhesive layer and the filter sheet. 40 . The therapy delivery patch of claim 38 , wherein the therapeutic agent repository is situated between the flow controller and a top of the dome.
of pneumatic type · CPC title
Electromagnetic, inductive or dielectric measuring means · CPC title
Using a biosensor · CPC title
combined with drug delivery · CPC title
Mats · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.